{"annotatable":{"parts":["s1v1","s2v1","s3v1","s4v1","s5v1","s6v1","s7v1"]},"anncomplete":true,"sources":[],"metas":{"m_82":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_83":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_84":{"value":"Low-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_85":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_86":{"value":"Some-concerns","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}},"m_35":{"value":"High-risk","confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1}}},"entities":[{"classId":"e_109","part":"s1v1","offsets":[{"start":2,"text":"randomised clinical trial"}],"coordinates":[{"x":"55.79","y":"105.53"},{"x":"239.34","y":"115.38"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_109","part":"s1v1","offsets":[{"start":778,"text":"were randomised to thecontrol group"}],"coordinates":[{"x":"444.42","y":"262.26"},{"x":"105.55","y":"277.76"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_132","part":"s2v1","offsets":[{"start":2679,"text":"They were randomised to two treatment groups: the control group (n ¼ 25), in which modifiedradical mastectomy was performed without any intervention priorto surgery; or the HIFU group (n ¼ 23), in which extracorporeal insitu ablation of the breast cancer with HIFU was followed bymodified radical mastectomy within 1 – 2 weeks."}],"coordinates":[{"x":"182.21","y":"571.76"},{"x":"492.64","y":"105.40"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_107","part":"s2v1","offsets":[{"start":2679,"text":"They were randomised to two treatment groups: the control group (n ¼ 25), in which modifiedradical mastectomy was performed without any intervention priorto surgery; or the HIFU group (n ¼ 23), in which extracorporeal insitu ablation of the breast cancer with HIFU was followed bymodified radical mastectomy within 1 – 2 weeks."}],"coordinates":[{"x":"182.21","y":"571.76"},{"x":"492.64","y":"105.40"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_159","part":"s2v1","offsets":[{"start":2726,"text":"he control group (n ¼ 25), in which modifiedradical mastectomy was performed without any intervention priorto surgery; or the HIFU group (n ¼ 23),"}],"coordinates":[{"x":"385.19","y":"61.07"},{"x":"458.24","y":"85.45"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_121","part":"s2v1","offsets":[{"start":5426,"text":"Table 1 Characteristics of eligible patients in both groupsCharacteristics Control group HIFU groupNo. of patients 25 23Age (years) 45.571.2 46.571.7Tumour diameter (cm) 3.570.23 (1.8 – 5.6) 3.170.79 (2.0 – 4.7)HistologyInvasive 21 21Noninvasive 4 2Node statusN0 13 12N1 6 5N2 6 6TNMI 2 2II 22 21III 1 0"}],"coordinates":[{"x":"311.36","y":"544.33"},{"x":"507.12","y":"727.33"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_186","part":"s3v1","offsets":[{"start":4160,"text":"The number of immunostained cells was counted in amicroscopic grid, 0.5 \u0003 0.5 mm2 in size (0.25 mm2), using amicroscopic field of \u0003 200. A total of 10 areas with the mostabundant distribution were chosen in each case for this observa-tion. Two independent observers judged the distribution of thesethree variables and counted the positive cells. If the results wereinconsistent, the two observers discussed to reach a consensus onthe semi-quantitative scoring. For the PCNA, we used the labellingindex of PCNA in cancer cells to evaluate the result. The number ofPCNA þ cancer cells was counted among 100 cancer cells using a\u0003 200 microscopic field."}],"coordinates":[{"x":"310.85","y":"130.79"},{"x":"394.45","y":"234.89"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_191","part":"s3v1","offsets":[{"start":4400,"text":"Two independent observers judged the distribution of thesethree variables and counted the positive cells. If the results wereinconsistent, the two observers discussed to reach a consensus onthe semi-quantitative scoring."}],"coordinates":[{"x":"322.13","y":"170.66"},{"x":"412.83","y":"205.01"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_217","part":"s3v1","offsets":[{"start":4829,"text":"All observed data are displayed as the mean value plus or minusthe standard deviation. The statistical significance of any observeddifference between the mean values of control and treatmentgroups was evaluated using an unpaired Student’s t-test. Thevariability in data was compared with the F test for variance. Thedifferences in percentage data were analysed by using the Fisher’sexact test. Statistical significance was defined as a P-value of lessthan 0.05."}],"coordinates":[{"x":"301.89","y":"269.30"},{"x":"338.73","y":"343.51"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_212","part":"s3v1","offsets":[{"start":4829,"text":"All observed data are displayed as the mean value plus or minusthe standard deviation. The statistical significance of any observeddifference between the mean values of control and treatmentgroups was evaluated using an unpaired Student’s t-test. Thevariability in data was compared with the F test for variance. Thedifferences in percentage data were analysed by using the Fisher’sexact test. Statistical significance was defined as a P-value of lessthan 0.05"}],"coordinates":[{"x":"301.89","y":"269.30"},{"x":"336.58","y":"343.51"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_159","part":"s3v1","offsets":[{"start":5317,"text":"Among 23 patients, 16 cases underwent surgery at 7 – 10 days afterHIFU ablation, and the remaining seven patients were operated at11 – 14 days. After HIFU, oedema was noted in the mammary tissuesurrounding the treated tumour. In all cases, the treated areaincluded the tumour and a 1.5 – 2.0 cm margin of normal breasttissue around the tumour. At 7 – 10 days postoperatively, theoedema gradually disappeared. In total, 14 patients experiencedmild local pain, warmth, and sensation of heaviness in the diseasedbreast. But only four patients were given 3 – 5 days prescription fororal analgesics. One patient had minimal skin burn, which hadentirely recovered by 10 days post-HIFU. There was no incidenceof bleeding or infection of the treated breast requiring interven-tion. Three patients received one MRI examination after HIFUtreatment. Compared with preprocedural images, enhanced MRIrevealed the absence of contrast enhancement in the treated regionincluding tumour and 1.5 – 2.0 cm normal breast tissue surround-ing the tumour (see Figure 2), indicative of coagulative necrosis."}],"coordinates":[{"x":"301.89","y":"400.83"},{"x":"546.50","y":"564.67"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}},{"classId":"e_159","part":"s3v1","offsets":[{"start":5317,"text":"Among 23 patients, 16 cases underwent surgery at 7 – 10 days afterHIFU ablation, and the remaining seven patients were operated at11 – 14 days. A"}],"coordinates":[{"x":"301.89","y":"400.83"},{"x":"354.86","y":"425.21"}],"confidence":{"state":"pre-added","who":["user:roger-annotation"],"prob":1},"fields":{},"normalizations":{}}],"relations":[]}